GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Visgeneer Inc (ROCO:4197) » Definitions » Ending Cash Position

Visgeneer (ROCO:4197) Ending Cash Position : NT$70.4 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Visgeneer Ending Cash Position?

Visgeneer's Ending Cash Position for the quarter that ended in Dec. 2024 was NT$70.4 Mil.

Visgeneer's quarterly Ending Cash Position declined from Dec. 2023 (NT$127.3 Mil) to Jun. 2024 (NT$97.2 Mil) and declined from Jun. 2024 (NT$97.2 Mil) to Dec. 2024 (NT$70.4 Mil).

Visgeneer's annual Ending Cash Position declined from Dec. 2022 (NT$185.3 Mil) to Dec. 2023 (NT$127.3 Mil) and declined from Dec. 2023 (NT$127.3 Mil) to Dec. 2024 (NT$70.4 Mil).

Visgeneer Ending Cash Position Historical Data

The historical data trend for Visgeneer's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visgeneer Ending Cash Position Chart

Visgeneer Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.42 88.13 185.34 127.32 70.42

Visgeneer Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 185.34 121.58 127.32 97.20 70.42

Visgeneer Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Visgeneer's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=127.322+-56.905
=70.4

Visgeneer's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=97.198+-26.781
=70.4

Visgeneer Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Visgeneer's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Visgeneer Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Visgeneer Inc (ROCO:4197) » Definitions » Ending Cash Position
Comparable Companies
ROCO:6744 ROCO:6848 ROCO:7607 ROCO:6876 ROCO:4170 ROCO:6827 ROCO:6549 ROCO:6917 ROCO:3205 ROCO:6999 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Number 335, Section 6, Zhonghua Road, Xiangshan District, Hsinchu, TWN, 30094
Website
https://www.visgeneer.com.tw
Visgeneer Inc is a Taiwan based Biotech company involved in developing and, manufacturing biomedical products in the areas of Bacterial Fermentation, Medical Device, Cosmetics/Skin Care, and Cancer Gene identification. Its products include Blood Glucose and Ketone Monitoring System, Ginkgo Biloba series, Peptide-Complex series, Hyaluronic Acid Essence Series and High-Quality Masks among others.

Visgeneer Headlines

No Headlines